| Trial Identifier: | D7350C00001 |
| Sponsor: | AstraZeneca |
| Start Date: | July 2025 |
| Primary Completion Date: | April 2029 |
| Study Completion Date: | April 2029 |
| Condition: | Cancer - Other; Skin Cancer; Lung Cancer; Breast Cancer |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| AU | East Melbourne, AU, 3002 |
| JP | Chuo-ku, JP, 104-0045 |
| JP | Kashiwa, JP, 227-8577 |
| US, MI | Grand Rapids, MI, US, 49546 |
| US, TX | Houston, TX, US, 77030 |
| US, TX | San Antonio, TX, US, 78229 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company